Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Ionis Pharmaceuticals | IONS - Laba Operasional
Keuangan
Harga Saham
USD
Aktiva
USD 2.99B
Kas Dan Setara
USD 350.07M
Biaya Penjualan
USD 2.74M
Aset Lancar
USD 2.49B
Kewajiban Lancar
USD 315.64M
UTANG
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
Karyawan
1.07K
Eps Laba Per Saham
USD -0.69
Modal Dan Cadangan
USD 439.74M
Laba Kotor Pada Penjualan
USD 265M
Beban Bunga Utang
USD 18M
Pendapatan Bunga
USD -0.66
Modal Pinjaman
USD 1.91B
Kapitalisasi Pasar
USD 8.61B
Batas Pemasukan
USD -114.65M
Biaya Operasional
USD 370.24M
Laba Operasional
USD -102.29M
Modal Saham Biasa
USD 165.64M
Pe Harga Untuk Laba
396.15
Laba Sebelum Pajak
USD -114M
Pendapatan Penjualan
USD 268M
Beban Penjualan Dan Administrasi
USD 130.08M
Saham
USD 50.83M
Kreditur Perdagangan
USD 47.7M
Debitur Perdagangan
USD 58.85M
Laba Operasional
Perubahan
Tanggal
Agios Pharmaceuticals
USD -110.02M
11.55M
2026-03
Alnylam Pharmaceuticals
USD 112.6M
24.99M
2026-06
Arrowhead Research
USD -170.09M
28.83M
2026-06
Astellas Pharma
JPY 185.36B
136.79B
2026-06
BioCryst Pharmaceuticals
USD 98.46M
161.92M
2026-06
BioMarin Pharmaceutical
USD 105.6M
24.04M
2026-06
Celltrion
KRW 12.9B
822.77M
2026-03
Cspc Pharmaceutical
CNY 206.26M
1.02B
2025-12
Deva Holding AS
TRY 964.87M
240.32M
2023-09
Divis Laboratories Ltd
INR 11.29B
3.15B
2026-06
Exelixis
USD 248.41M
2.93M
2026-06
Halozyme Therapeutics
USD -63.72M
1.95M
2026-06
Ionis Pharmaceuticals
USD -102.29M
15.71M
2026-06
Kangmei Pharma
CNY -10.94M
15.75M
2026-03
Knight Therapeutics
CAD 6.21M
3.27M
2025-12
Laboratorios Farma
EUR 135.05M
49.84M
2023-12
Malin Corporation
EUR -1.1M
400K
2024-12
Medical Developments International
AUD -36K
444K
2025-12
Moderna
USD -815M
573M
2026-06
Nektar Therapeutics
USD -38.26M
19.17M
2026-03
Neuren Pharmaceuticals
AUD 17.01M
11.56M
2025-12
Neurocrine Biosciences
USD 219.9M
5.3M
2026-06
Novartis
USD 4.75B
515M
2026-06
Omeros
USD -35.41M
23.75M
2024-09
OPKO Health
USD -51.02M
12.7M
2026-03
Organigram Holdings
CAD -9.79M
10.33M
2026-03
Ovoca Bio
EUR -173K
990K
2025-12
Pfizer
USD 667M
4.32B
2026-06
Pharma Mar
EUR -1.4M
2.03M
2026-06
PTC Therapeutics
USD 45.89M
127.51M
2026-03
Qiagen NV
USD 141.4M
24.77M
2026-06
Regeneron Pharmaceuticals
USD 1.42B
675.7M
2026-06
Roche Holding
CHF 11.46B
1.91B
2026-06
Sarepta Therapeutics
USD 13.29M
345.14M
2026-06
Sartorius
EUR 164M
3.3M
2026-06
Sino Biopharmaceutical
CNY 5.18B
3.32B
2025-06
Tilray
USD -20.01M
9.34M
2025-09
Ultragenyx Pharmaceutical
USD -75M
141M
2026-06
Vertex Pharmaceuticals
USD 1.27B
129.9M
2026-06
Zealand Pharma A/S
-539M
168.05M
2026-03
Zz Pientze Pharmaceu
CNY 362.83M
474.98M
2026-06
×